Evidence map›Paper›PMID 33199895›Full record

ArticleNature metabolism2020

The PI3K pathway preserves metabolic health through MARCO-dependent lipid uptake by adipose tissue macrophages.

Julia S Brunner, Andrea Vogel, Alexander Lercher, Michael Caldera, Ana Korosec, Marlene Pühringer, Melanie Hofmann, Alexander Hajto, Markus Kieler, Lucia Quemada Garrido and 18 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. TREM2 promotes adipogenesis of PDGFR-αFrontiers in endocrinology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Aberrant Lipid Metabolism in Macrophages Is Associated with Granuloma Formation in Sarcoidosis.American journal of respiratory and critical care medicine · 2024
    Article
  7. Review
  8. Article
  9. Dietary fat and lipid metabolism in the tumor microenvironment.Biochimica et biophysica acta. Reviews on cancer · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. Role of adipose tissue macrophages in obesity-related disorders.The Journal of experimental medicine · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 5 countries.

Julia S Brunner *Institute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-3195-147X
Andrea Vogel *Institute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-2613-140X
Alexander LercherCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0003-3478-5304
Michael CalderaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Ana KorosecSkin and Endothelium Research Division, Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Marlene PühringerInstitute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-2364-0102
Melanie HofmannInstitute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-0835-4183
Alexander HajtoInstitute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.
Markus KielerInstitute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-4082-5731
Lucia Quemada GarridoInstitute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.
Martina KerndlInstitute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-5060-8944
Mario KuttkeInstitute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-3517-2841
Ildiko MesteriInstitute of Pathology Überlingen, Überlingen, Germany.
Maria W GórnaBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-1769-4542
Marta KulikBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0003-2381-7665
Paulina M DominiakBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw, Warsaw, Poland.ORCID http://orcid.org/0000-0002-1466-1243
Amanda E BrandonInsulin Action and Energy Metabolism Laboratory, Division of Diabetes & Metabolism, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Emma EstevezCellular & Molecular Metabolism Laboratory, Division of Diabetes & Metabolism, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Casey L EganCellular & Molecular Metabolism Laboratory, Division of Diabetes & Metabolism, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Florian GruberResearch Division of Biology and Pathobiology of the Skin, Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Martina SchweigerInstitute of Molecular Biosciences, University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-3419-1007
Jörg MencheCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0002-1583-6404
Andreas BergthalerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Thomas WeichhartCenter of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-4349-0797
Kristaps KlavinsCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Mark A FebbraioCellular & Molecular Metabolism Laboratory, Division of Diabetes & Metabolism, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.ORCID http://orcid.org/0000-0002-9296-4418
Omar Sharif *Institute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria. omar.sharif@meduniwien.ac.at.ORCID http://orcid.org/0000-0001-7899-2343
Gernot Schabbauer *Institute for Vascular Biology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria. gernot.schabbauer@meduniwien.ac.at.ORCID http://orcid.org/0000-0002-7490-8009
Christian Doppler Laboratory for Thermoelectricity · ATAustrian Academy of Sciences · ATGarvan Institute of Medical Research · AUMedical University of Vienna · ATUniversity of Warsaw · PLAkademie Überlingen (Germany) · DEThe University of Sydney · AUUniversity of Graz · AT

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) 31106Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) 31568Austrian Science Fund FWF P 30026Department of Health | National Health and Medical Research Council (NHMRC) APP1116936EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 677006Österreichischen Akademie der Wissenschaften (Austrian Academy of Sciences) DOC
6 · The paper itself

Abstract

Adipose tissue macrophages (ATMs) display tremendous heterogeneity depending on signals in their local microenvironment and contribute to the pathogenesis of obesity. The phosphoinositide 3-kinase (PI3K) signalling pathway, antagonized by the phosphatase and tensin homologue (PTEN), is important for metabolic responses to obesity. We hypothesized that fluctuations in macrophage-intrinsic PI3K activity via PTEN could alter the trajectory of metabolic disease by driving distinct ATM populations. Using mice harbouring macrophage-specific PTEN deletion or bone marrow chimeras carrying additional PTEN copies, we demonstrate that sustained PI3K activity in macrophages preserves metabolic health in obesity by preventing lipotoxicity. Myeloid PI3K signalling promotes a beneficial ATM population characterized by lipid uptake, catabolism and high expression of the scavenger macrophage receptor with collagenous structure (MARCO). Dual MARCO and myeloid PTEN deficiencies prevent the generation of lipid-buffering ATMs, reversing the beneficial actions of elevated myeloid PI3K activity in metabolic disease. Thus, macrophage-intrinsic PI3K signalling boosts metabolic health by driving ATM programmes associated with MARCO-dependent lipid uptake.

Indexed as

Signal TransductionAdipocytesAdipose TissueAnimalsBone Marrow TransplantationCell DifferentiationChimeraGlucose Tolerance TestLipid MetabolismLipidomicsMacrophagesMetabolic DiseasesMiceMice, Inbred C57BLObesityPhosphatidylinositol 3-KinasesMarco protein, mousePhosphatidylinositol 3-KinasesPTEN PhosphohydrolasePten protein, mouseReceptors, Immunologic

Identifiers

PMID33199895
OpenAlexW3102735578

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.